22 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
product.
For any approved product, we will be subject to ongoing regulatory obligations and extensive oversight by regulatory authorities, including … and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these laws
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
oversight by regulatory authorities, including with respect to manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage … , additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations
8-K
EX-99.1
ZYME
Zymeworks Inc.
28 Mar 24
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
4:16pm
governance and oversight required for the next stage of the Company’s development and growth,” said Kenneth Galbraith, Chair and Chief Executive
8-K
EX-10.1
cij5 3tbf9id0wsmt
16 May 23
Entry into a Material Definitive Agreement
8:30am
424B5
5y1 t2ta5ohsp7nrn
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
on6h mdqtxe
8 May 23
Prospectus supplement for primary offering
5:18pm
DEFA14A
lh1sum 7iclj6cm
8 Dec 22
Additional proxy soliciting materials
8:31am
DEF 14A
yyb fu9kr
25 Nov 22
Definitive proxy
6:16am
424B5
43f8s
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
2sjsu
8 Nov 22
Quarterly report
4:09pm
424B5
qeratq o3
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
opmi2asi
13 Oct 22
Prospectus supplement for primary offering
4:56pm
424B3
2y8ewld5j3jwe6iq16s
2 Sep 22
Prospectus supplement
4:06pm